Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mück

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1996
No interethnic differences in stereoselective disposition of oral nimodipine between Caucasian and Japanese subjectsW Mück, T Tanaka, G Ahr, et al.
British Journal of Clinical Pharmacology|July 15, 1998
Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatinW Mück, S Unger, K Kawano, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 3, 1998
The effect of omeprazole pre- and cotreatment on cerivastatin absorption and metabolism in manR Sachse, K Ochmann, G Rohde, et al.
European Journal of Clinical Investigation|February 1, 1991
Hyperaluminaemia in critically ill patients: role of antacid therapy and impaired renal functionT H Ittel, U Gladziwa, W Mück, et al.
Journal of Pharmaceutical Sciences|March 1, 1993
Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope techniqueC Fischer, F Schönberger, W Mück, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatinW Mück, K Ochmann, G Rohde, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1997
Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatinW Mück, W Ritter, H Dietrich, et al.
Journal of Chromatography|December 23, 1988
On-line capillary zone electrophoresis-ion spray tandem mass spectrometry for the determination of dynorphinsE D Lee, W Mück, J D Henion, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 4, 1999
Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysisD Terziivanov, I Atanasova, V Dimitrova, et al.
British Journal of Anaesthesia|May 1, 1995
Continuous infusion of nimodipine during coronary artery surgery: haemodynamic and pharmacokinetic studyM Hynynen, T Siltanen, A Sahlman, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1996
No interethnic differences in stereoselective disposition of oral nimodipine between Caucasian and Japanese subjectsW Mück, T Tanaka, G Ahr, et al.
British Journal of Clinical Pharmacology|July 15, 1998
Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatinW Mück, S Unger, K Kawano, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 3, 1998
The effect of omeprazole pre- and cotreatment on cerivastatin absorption and metabolism in manR Sachse, K Ochmann, G Rohde, et al.
European Journal of Clinical Investigation|February 1, 1991
Hyperaluminaemia in critically ill patients: role of antacid therapy and impaired renal functionT H Ittel, U Gladziwa, W Mück, et al.
Journal of Pharmaceutical Sciences|March 1, 1993
Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope techniqueC Fischer, F Schönberger, W Mück, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatinW Mück, K Ochmann, G Rohde, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1997
Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatinW Mück, W Ritter, H Dietrich, et al.
Journal of Chromatography|December 23, 1988
On-line capillary zone electrophoresis-ion spray tandem mass spectrometry for the determination of dynorphinsE D Lee, W Mück, J D Henion, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 4, 1999
Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysisD Terziivanov, I Atanasova, V Dimitrova, et al.
British Journal of Anaesthesia|May 1, 1995
Continuous infusion of nimodipine during coronary artery surgery: haemodynamic and pharmacokinetic studyM Hynynen, T Siltanen, A Sahlman, et al.
Pageof 4